Search research articles
Contact Us
Filters
Showing results (31-40 of 1,137) with videos related to
Page
of 114
Sort By:
Critical Pathways in Cardiology
|
March 15, 2008
Update to International Classification of Diseases, 9th Revision codes: distinguishes STEMI from NSTEMI
Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
Critical Pathways in Cardiology: a journal of evidence-based medicine: translating evidence into practice
Christopher P Cannon
Clinical Cornerstone
|
February 14, 2006
The endocannabinoid system: a new approach to control cardiovascular disease
Christopher P Cannon
American Heart Journal
|
January 8, 1999
Timely thrombolysis: synergism to open arteries and reduce mortality rates
C P Cannon
Journal of the American College of Cardiology
|
August 27, 2013
Should we measure quality by the dose?
Christopher P Cannon
European Heart Journal
|
August 22, 2020
Chronic kidney disease: a high-risk group that deserves intensive lipid lowering
Christopher P Cannon
Lancet (London, England)
|
April 3, 2009
Can the polypill save the world from heart disease?
Christopher P Cannon
Journal of the American College of Cardiology
|
March 27, 2020
Low-Density Lipoprotein Cholesterol: Lower Is Totally Better
Christopher P Cannon
JAMA
|
April 19, 2002
Primary percutaneous coronary intervention for all?
Christopher P Cannon
Lancet (London, England)
|
February 20, 2010
Balancing the benefits of statins versus a new risk-diabetes
Christopher P Cannon
Page
of 114
Search research articles
Search
Showing results (31-40 of 1,137) with videos related to
Sort By:
Page
of 114
Critical Pathways in Cardiology
|
March 15, 2008
Update to International Classification of Diseases, 9th Revision codes: distinguishes STEMI from NSTEMI
Christopher P Cannon
Critical Pathways in Cardiology
|
March 15, 2008
Critical Pathways in Cardiology: a journal of evidence-based medicine: translating evidence into practice
Christopher P Cannon
Clinical Cornerstone
|
February 14, 2006
The endocannabinoid system: a new approach to control cardiovascular disease
Christopher P Cannon
American Heart Journal
|
January 8, 1999
Timely thrombolysis: synergism to open arteries and reduce mortality rates
C P Cannon
Journal of the American College of Cardiology
|
August 27, 2013
Should we measure quality by the dose?
Christopher P Cannon
European Heart Journal
|
August 22, 2020
Chronic kidney disease: a high-risk group that deserves intensive lipid lowering
Christopher P Cannon
Lancet (London, England)
|
April 3, 2009
Can the polypill save the world from heart disease?
Christopher P Cannon
Journal of the American College of Cardiology
|
March 27, 2020
Low-Density Lipoprotein Cholesterol: Lower Is Totally Better
Christopher P Cannon
JAMA
|
April 19, 2002
Primary percutaneous coronary intervention for all?
Christopher P Cannon
Lancet (London, England)
|
February 20, 2010
Balancing the benefits of statins versus a new risk-diabetes
Christopher P Cannon
Page
of 114